These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 22512779)
1. Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes. Kumaraswamy SB; Linder A; Åkesson P; Dahlbäck B Crit Care; 2012 Dec; 16(2):R60. PubMed ID: 22512779 [TBL] [Abstract][Full Text] [Related]
2. Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons. Frej C; Linder A; Happonen KE; Taylor FB; Lupu F; Dahlbäck B J Cell Mol Med; 2016 Jun; 20(6):1170-81. PubMed ID: 26990127 [TBL] [Abstract][Full Text] [Related]
3. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism. Karuna R; Park R; Othman A; Holleboom AG; Motazacker MM; Sutter I; Kuivenhoven JA; Rohrer L; Matile H; Hornemann T; Stoffel M; Rentsch KM; von Eckardstein A Atherosclerosis; 2011 Dec; 219(2):855-63. PubMed ID: 21944699 [TBL] [Abstract][Full Text] [Related]
4. A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex. Frej C; Mendez AJ; Ruiz M; Castillo M; Hughes TA; Dahlbäck B; Goldberg RB Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1194-1205. PubMed ID: 28385702 [TBL] [Abstract][Full Text] [Related]
5. The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles. Christoffersen C; Benn M; Christensen PM; Gordts PLSM; Roebroek AJM; Frikke-Schmidt R; Tybjaerg-Hansen A; Dahlbäck B; Nielsen LB J Lipid Res; 2012 Oct; 53(10):2198-2204. PubMed ID: 22826357 [TBL] [Abstract][Full Text] [Related]
6. Involvement of CETP (Cholesteryl Ester Transfer Protein) in the Shift of Sphingosine-1-Phosphate Among Lipoproteins and in the Modulation of its Functions. Kurano M; Hara M; Ikeda H; Tsukamoto K; Yatomi Y Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):506-514. PubMed ID: 28126827 [TBL] [Abstract][Full Text] [Related]
8. Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case-control study. Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Tao Q; Zhang Y Lipids Health Dis; 2016 Sep; 15(1):158. PubMed ID: 27633510 [TBL] [Abstract][Full Text] [Related]
9. Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein. Liu M; Seo J; Allegood J; Bi X; Zhu X; Boudyguina E; Gebre AK; Avni D; Shah D; Sorci-Thomas MG; Thomas MJ; Shelness GS; Spiegel S; Parks JS J Biol Chem; 2014 Jan; 289(5):2801-14. PubMed ID: 24318881 [TBL] [Abstract][Full Text] [Related]
10. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1. Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252 [TBL] [Abstract][Full Text] [Related]
11. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice. Christoffersen C; Jauhiainen M; Moser M; Porse B; Ehnholm C; Boesl M; Dahlbäck B; Nielsen LB J Biol Chem; 2008 Jan; 283(4):1839-47. PubMed ID: 18006500 [TBL] [Abstract][Full Text] [Related]
12. LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate. Kurano M; Tsukamoto K; Hara M; Ohkawa R; Ikeda H; Yatomi Y J Biol Chem; 2015 Jan; 290(4):2477-88. PubMed ID: 25505264 [TBL] [Abstract][Full Text] [Related]
13. Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men. Ooi EM; Watts GF; Chan DC; Nielsen LB; Plomgaard P; Dahlbäck B; Barrett PH Atherosclerosis; 2010 May; 210(1):326-30. PubMed ID: 20031132 [TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of human apolipoprotein M-containing lipoproteins. Christoffersen C; Nielsen LB; Axler O; Andersson A; Johnsen AH; Dahlbäck B J Lipid Res; 2006 Aug; 47(8):1833-43. PubMed ID: 16682745 [TBL] [Abstract][Full Text] [Related]
15. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus. Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663 [TBL] [Abstract][Full Text] [Related]
16. Relationship of plasma apolipoprotein M with proprotein convertase subtilisin-kexin type 9 levels in non-diabetic subjects. Kappelle PJ; Lambert G; Dahlbäck B; Nielsen LB; Dullaart RP Atherosclerosis; 2011 Feb; 214(2):492-4. PubMed ID: 21122852 [TBL] [Abstract][Full Text] [Related]
17. Protein unfolding allows use of commercial antibodies in an apolipoprotein M sandwich ELISA. Bosteen MH; Dahlbäck B; Nielsen LB; Christoffersen C J Lipid Res; 2015 Mar; 56(3):754-759. PubMed ID: 25561460 [TBL] [Abstract][Full Text] [Related]
18. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins. Zhang B; Tomura H; Kuwabara A; Kimura T; Miura S; Noda K; Okajima F; Saku K Atherosclerosis; 2005 Jan; 178(1):199-205. PubMed ID: 15585219 [TBL] [Abstract][Full Text] [Related]
19. Stable Isotope Kinetic Study of ApoM (Apolipoprotein M). Croyal M; Billon-Crossouard S; Goulitquer S; Aguesse A; León L; Fall F; Chétiveaux M; Moyon T; Blanchard V; Ouguerram K; Lambert G; Nobécourt E; Krempf M Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):255-261. PubMed ID: 29146748 [TBL] [Abstract][Full Text] [Related]
20. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis. Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]